News & Updates
Filter by Specialty:
High acute-to-chronic glycaemic ratio tied to worse prognosis in T2D patients with COVID-19
Type 2 diabetes (T2D) patients with COVID-19 who have elevated acute-to-chronic (A/C) glycaemic ratio are at increased risk of adverse outcomes, including in-hospital mortality, intensive care unit (ICU) admission, and mechanical ventilation, a study has found.
High acute-to-chronic glycaemic ratio tied to worse prognosis in T2D patients with COVID-19
23 Nov 2021
Amphilimus-eluting stents: As good as zotarolimus-eluting stents in patients with diabetes?
The use of amphilimus-eluting stents (AES) in patients with diabetes mellitus undergoing percutaneous revascularization was less likely to result in target lesion or target vessel failure compared with zotarolimus-eluting stents (ZES) at 1 year, according to findings of the SUGAR trial presented at TCT 2021.
Amphilimus-eluting stents: As good as zotarolimus-eluting stents in patients with diabetes?
22 Nov 2021
Resveratrol supplements confer minimal benefits in T2D, MetS, NAFLD
Supplementation with resveratrol does not appear to provide much benefit in the management of cardiometabolic risk factors in patients with type 2 diabetes (T2D), metabolic syndrome (MetS), and nonalcoholic fatty liver disease (NAFLD), suggests a study.
